SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007469
Filing Date
2024-05-09
Accepted
2024-05-09 07:30:49
Documents
89
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20240331x10q.htm   iXBRL 10-Q 1467497
2 EX-31.1 ipsc-20240331xex31d1.htm EX-31.1 14637
3 EX-31.2 ipsc-20240331xex31d2.htm EX-31.2 14494
4 EX-32.1 ipsc-20240331xex32d1.htm EX-32.1 6972
5 EX-32.2 ipsc-20240331xex32d2.htm EX-32.2 6987
6 GRAPHIC ipsc-20240331xex31d1001.jpg GRAPHIC 939
7 GRAPHIC ipsc-20240331xex31d2001.jpg GRAPHIC 939
  Complete submission text file 0001558370-24-007469.txt   7588718

Data Files

Seq Description Document Type Size
8 EX-101.SCH ipsc-20240331.xsd EX-101.SCH 56425
9 EX-101.CAL ipsc-20240331_cal.xml EX-101.CAL 60852
10 EX-101.DEF ipsc-20240331_def.xml EX-101.DEF 223846
11 EX-101.LAB ipsc-20240331_lab.xml EX-101.LAB 491400
12 EX-101.PRE ipsc-20240331_pre.xml EX-101.PRE 395824
93 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20240331x10q_htm.xml XML 1288967
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 24928588
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)